The P2 purinergic receptors of human dendritic cells: Identification and coupling to cytokine release

FASEB Journal

Volumn 14, Issue 15, 2000, Pages 2466-2476

  Ferrari, D ^a   La Sala, A ^a   Chiozzi, P ^a   Morelli, A ^a   Falzoni, S ^a   Girolomoni, G ^a   Idzko, M ^a   Dichmann, S ^a   Norgauer, J ^a   Di Virgilio, F ^a  

^a UNIVERSITY OF FERRARA   (Italy)

Author keywords

Extracellular nucleotides; IL 1 ; Inflammation; Nucleotide receptors; TNF

Indexed keywords

1 [N,O BIS(5 ISOQUINOLINESULFONYL) N METHYLTYROSYL] 4 PHENYLPIPERAZINE; 2',3' (4 BENZOYL BENZOYL) ADENOSINE TRIPHOSPHATE; ADENOSINE TRIPHOSPHATE; ADENOSINE TRIPHOSPHATE DERIVATIVE; CALCIUM; CYTOKINE; ETHIDIUM BROMIDE; INTERLEUKIN 1BETA; LIGAND; LUCIFER YELLOW; NUCLEOTIDE; PURINE P2 RECEPTOR; PURINE P2X RECEPTOR; PURINE P2Y RECEPTOR; RECEPTOR SUBTYPE; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ARTICLE; CALCIUM CELL LEVEL; CELL FUNCTION; CELL MEMBRANE DEPOLARIZATION; CYTOKINE RELEASE; CYTOTOXICITY; DENDRITIC CELL; HUMAN; HUMAN CELL; INFLAMMATION; PRIORITY JOURNAL; PROTEIN EXPRESSION; RECEPTOR BINDING;

EID: 0033669308     PISSN: 08926638     EISSN: None     Source Type: Journal    
DOI: 10.1096/fj.00-0031com     Document Type: Article

References (54)

1. Dendritic cells and the control of immunity
2. The dendritic cell system and its role in immunogenicity
3. Dendritic cells: Unique leukocyte populations which control the primary immune response
4. Natural adjuvants: Endogenous activators of dendritic cells
5. 7 purinergic receptor: Characterization and possible participation in antigen presentation
6. Nucleotide receptors
7. Receptors for purines and pyrimidines
8. The P2Z purinoceptor: An intriguing role in immunity, inflammation and cell death
9. Role of extracellular ATP and P1 and P2 classes of purinergic receptors in T-cell development and cytotoxic T lymphocyte effector functions
10. Purinoceptors: Are there families of P2X and P2Y purinoceptors?
11. Expression and a role of functionally coupled P2Y receptors in human dendritic cells
12. Cytolytic P2X purinoceptors
13. 7 receptor in the immune system
14. 7)
15. The purinergic P2Z receptor of human macrophage cells: Characterization and possible physiological role
16. 7 nucleotide receptor expression by pro- and anti-inflammatory stimuli in THP-1 monocytes
17. 7 ATP receptor
18. Interleukin-1 beta maturation and release in response to ATP and nigericin. Evidence that potassium depletion mediated by these agents is a necessary and common feature of their activity
19. Mouse microglial cells express a plasma membrane pore gated by extracellular ATP
20. Extracellular ATP triggers IL-1β release by activating the purinergic P2Z receptor of human macrophages
21. Efficient presentation of soluble antigen by cultured human dendritic cells is maintained by granulocyte/macrophage colony-stimulating factor plus interleukin 4 and downregulated by tumor necrosis factor α
22. ATP4- permeabilizes the plasma membrane of mouse macrophages to fluorescent dyes
23. P2Z adenosine triphosphate receptor activity in cultured human monocyte-derived macrophages
24. An ATP-activated channel is involved in mitogenic stimulation of human T lymphocytes
25. Responses to extracellular ATP of lymphoblastoid cell lines from Duchenne muscular dystrophy patients
26. Extracellular sodium regulates airway ciliary motility by inhibiting a P2X receptor
27. A novel pathway for the activation of phospholipase D by P2Z purinergic receptors in BAC1.2F5 macrophages
28. Oxidized ATP. An irreversible inhibitor of the macrophage purinergic P2Z receptor
29. The isoquinoline derivative KN-62, a potent antagonist of the P2Z-receptor of human lymphocytes
30. 7 receptor coupled to ion fluxes, microvesicle formation and IL-6 release
31. 7 receptor function with a monoclonal antibody
32. Release of IL-1 from mononuclear phagocytes
33. IL-1 beta maturation: Evidence that mature cytokine formation can be induced specifically by nigericin
34. Nucleotide receptors: An emerging family of regulatory molecules in blood cells
35. Purinergic receptor modulation of lipopolysaccharide signalling and inducible nitric-oxide synthase expression in RAW 264.7 macrophages
36. 7-independent mechanism
37. Responses of mouse lymphocytes to extracellular adenosine 5'-triphosphate (ATP). Lymphocytes with cytotoxic activity are resistant to the permeabilizing effects of ATP
38. Effects of extracellular ATP and adenosine on different thymocyte subsets: Possible role of ATP-gated channels and G-protein-coupled purinergic receptors
39. 2+ mobilization and actin reorganization in human eosinophils
40. ATP-mediated cytotoxicity in microglial cells
41. 1, in thymocyte apoptosis
42. 7 receptor-dependent apoptosis of dendritic cells
43. Cloned ligand-gated channels activated by extracellular ATP (P2X receptors)
44. Pore dilation of neuronal P2X receptor channels
45. 3 receptor subunits can account for ATP-gated currents in sensory neurons
46. Rodent epidermal Langerhans cells demonstrate greater histochemical specificity for ADP than for ATP and AMP
47. Epidermal Langerhans cells are resistant to the permeabilizing effects of extracellular ATP: In vitro evidence supporting a protective role of membrane ATPase
48. Purinergic modulation of interleukin-1β release from microglial cells stimulated with bacterial endotoxin
49. A release mechanism for stored ATP in ocular ciliary epithelial cells
50. Connexins regulate calcium signalling by controlling ATP release
51. Cystic fibrosis transmembrane conductance regulator-associated ATP release is controlled by a chloride sensor
52. Loss of ATP diphosphohydrolase activity with endothelial cell activation
53. Post-translational processing of murine IL-1: Evidence that ATP-induced release of IL-1α and IL-1β occurs via a similar mechanism